Zobrazeno 1 - 10
of 655
pro vyhledávání: '"a antibody treatment"'
Autor:
Bethany M. Kwan, Chelsea Sobczak, Lindsey E. Fish, Adit A. Ginde, Gillian Grant, Mika K. Hamer, Kyle Leggott, Vanessa Owen, Jenna Reno, Justin Shrader, Lindsey Whittington, Jenn L. Jones, Ramona Koren, Joel A. Begay, Vall Vinaithirthan, Hillary D. Lum
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
IntroductionThroughout the COVID-19 pandemic, there was an urgent need for the rapid and equitable translation of knowledge and effective treatments to reach vulnerable populations in response to the ever-shifting pandemic environment. The approval o
Externí odkaz:
https://doaj.org/article/1bc457c7adc240fc9dfefad1a39f96fd
Autor:
Shuchen Feng, Gail E. Reid, Nina M. Clark, Amanda Harrington, Susan L. Uprichard, Susan C. Baker
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-13 (2024)
Abstract Background The factors contributing to the accelerated convergent evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not fully understood. Unraveling the contribution of viral replication in immunocompromised patie
Externí odkaz:
https://doaj.org/article/150d1d5111f24842bda4ee3c3ee35626
Autor:
Sergei S. Biryukov, Nathaniel O. Rill, Christopher P. Klimko, Jennifer L. Dankmeyer, Jennifer L. Shoe, Melissa Hunter, Yuli Talyansky, Derrick Hau, Marcellene A. Gates-Hollingsworth, Sujata G. Pandit, David P. Fetterer, Ju Qiu, Michael L. Davies, David P. AuCoin, Christopher K. Cote
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Yersinia pestis is a gram-negative bacterium that causes plague in animals and humans. Depending on the route of disease transmission, the bacterium can cause an acute, often fatal disease that has a narrow window for treatment with antibiotics. Addi
Externí odkaz:
https://doaj.org/article/7db42be64ce744c0889c6fe29fd90c42
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yu A. An, Wei Xiong, Shiuhwei Chen, Dawei Bu, Joseph M. Rutkowski, Joel P. Berger, Christine M. Kusminski, Ningyan Zhang, Zhiqiang An, Philipp E. Scherer
Publikováno v:
Molecular Metabolism, Vol 69, Iss , Pp 101680- (2023)
Objective: Renal fibrosis is a hallmark for chronic kidney disease (CKD), and often leads to end stage renal disease (ESRD). However, limited interventions are available clinically to ameliorate or reverse renal fibrosis. Methods: Herein, we evaluate
Externí odkaz:
https://doaj.org/article/6e8f7cde468443b19b2f998debea831b
Autor:
Laura Thümmler, Margarethe Konik, Monika Lindemann, Neslinur Fisenkci, Michael Koldehoff, Anja Gäckler, Peter A. Horn, Fotis Theodoropoulos, Christian Taube, Markus Zettler, Olympia Evdoxia Anastasiou, Peer Braß, Sarah Jansen, Oliver Witzke, Hana Rohn, Adalbert Krawczyk
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Immunocompromised patients are at increased risk for a severe course of COVID-19. Treatment of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection with anti-SARS-CoV-2 monoclonal antibodies (mAbs) has become widely accepted. Howeve
Externí odkaz:
https://doaj.org/article/960616c95cae4ed6b07d22684e10cfbd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giovanni Paolino, Sandra Buratta, Santo R. Mercuri, Roberto M. Pellegrino, Lorena Urbanelli, Carla Emiliani, Lucia Bertuccini, Francesca Iosi, Veronica Huber, Pina Brianti, Caterina Prezioso, Matteo R. Di Nicola, Cristina Federici, Luana Lugini
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Psoriasis is a chronic immune-mediated inflammatory skin disorder affecting children and adults. To date no approved biomarkers for diagnosis of this disease and follow up of patients have been translated into clinical practice. Recently, extracellul
Externí odkaz:
https://doaj.org/article/134266a8ae494c4ab335a12b24a8df2d
Autor:
Çaglar Çaglayan, Jonathan Thornhill, Miles A. Stewart, Anastasia S. Lambrou, Donald Richardson, Kaitlin Rainwater-Lovett, Jeffrey D. Freeman, Tiffany Pfundt, John T. Redd
Publikováno v:
Frontiers in Public Health, Vol 9 (2022)
BackgroundThe COVID-19 pandemic has significantly stressed healthcare systems. The addition of monoclonal antibody (mAb) infusions, which prevent severe disease and reduce hospitalizations, to the repertoire of COVID-19 countermeasures offers the opp
Externí odkaz:
https://doaj.org/article/4159c7417bd44bdeb9dcf0ec6bdf0d6c
Autor:
Gaetano Cicchitto, Lorena Cardillo, Davide Sequino, Paola Sabatini, Luisa Adamo, Rosita Marchitiello, Maurizio Viscardi, Loredana Cozzolino, Antonietta Cavallera, Marialuisa Bocchino, Alessandro Sanduzzi Zamparelli, Francesco Ferrigno, Esterina de Carlo, Claudio de Martinis, Giovanna Fusco
Publikováno v:
Viruses, Vol 15, Iss 1, p 102 (2022)
Neutralizing monoclonal antibodies (mAbs) for pre- and post-exposure prophylaxis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are largely used to prevent the progression of the disease by blocking viral attachment, host cell entry,
Externí odkaz:
https://doaj.org/article/86b5286ecdaf4dd8947bed8801be7868